Role of the nucleosome in the pathogenesis of systemic lupus erythematosus;Rôle du nucléosome dans la physiopathologie du lupus systémique

Annales de Medecine Interne

Volumn 154, Issue 1, 2003, Pages 25-32

  Amoura, Zahir ^a   Piette, Jean Charles ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Nucleosome; Pathophysiology; Systemic lupus

Indexed keywords

AUTOANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G3; NUCLEOSOME ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOIMMUNITY; CHROMATIN; CONFERENCE PAPER; HUMAN; IMMUNOPATHOGENESIS; NUCLEOSOME; PATHOPHYSIOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; AUTOANTIBODIES; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; HISTONES; HUMANS; IMMUNOGLOBULIN G; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MICE; NUCLEOSOMES;

EID: 0037310961     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (73)

1. TAN EM, SCHUR PH, CARR RI, KUNKEL HG: Deoxyribonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest, 1966; 45: 1732-40.
2. PINCUS T, SCHUR PH, ROZE JA, DECKER JL, TALAL N: Measurement of serum DNA binding activity in systemic lupus erythematosus. N Engl J Med, 1969; 281: 701-6.
3. TRON F, BACH JF: Relationship between antibodies to native DNA and glomerulonephritis in systemic lupus erythematosus. Clin Exp Immunol, 1977; 98: 426-32.
4. ISENBERG DA, SHOENFELD Y, SCHWARTZ RS: Multiple serologic reactions and their relationship to clinical activity in systemic lupus erythematosus. Arthritis Rheum, 1984; 27: 132-8.
5. WORRALL J, SNAITH ML, BATCHELOR R, ISENBERG DA: Systemic lupus erythematosus: a rheumatological view. Q J Med, 1990; 275: 319-30.
6. HARDIN JA: The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. Arthritis Rheum, 1986; 29: 457-60.
7. LUGER K, MADER AW, RICHMOND RK, SARGENT DF, RICHMOND TJ: Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature, 1997; 389: 251-60.
8. MC CONKEY DJ, ORRENIUS S, JONDAL M: Cellular signalling in programmed cell death (apoptosis). Immunol Today, 1990; 11: 120-6.
9. HARBECK RJ, BARDANA EJ, KOHLER PF, CARR RJ: DNA: anti-DNA complexes. Their detection in systemic lupus erythematosus sera. J Clin Invest, 1973; 52: 789-95.
10. SANO H, MORIMOTO C: Isolation of DNA from DNA/antiDNA immune complexes in systemic lupus erythematosus. J Immunol, 1981; 126: 536-40.
11. FOURNIE G: Circulating DNA and lupus nephritis. Kidney Int, 1988; 33: 487-97.
12. DAVIS GL, DAVIS JS: Detection of circulating DNA by counterimmunoelectrophoresis (CIE). Arthritis Rheum, 1973; 16: 52-8.
13. STEINMAN CR: Free DNA in serum and plasma from normal adults. J Clin Invest, 1975; 56: 512-5.
14. STEINMAN CR: Circulating DNA in systemic lupus erythematosus. Association with central nervous involvement and systemic vasculitis. Am J Med, 1979; 67: 429-35.
15. RAPTIS L, MENARD HA: Quantitation and characterization of plasma DNA in normals and patients with systemic lupus erythematosus. J Clin Invest, 1980; 66: 1391-9.
16. STEINMAN CR: Circulating DNA in systemic lupus erythematosus. Isolation and characterization. J Clin Invest, 1984; 73: 832-41.
17. JIN ZHAU LI, STEINMAN CR: Plasma DNA in systemic lupus erythematosus. Characterization of cloned base sequences. Arthritis Rheum, 1989; 32: 726-33.
18. RUMORE PM, STEINMAN CR: Endogenous circulating DNA in systemic lupus erythematosus. Occurrences as multimeric complexes bound to histones. J Clin Invest, 1990; 86: 471-7.
19. AMOURA Z, PIETTE JC, CHABRE H, CACOUB P, PAPO T, WECHSLER B, et al.: Circulating nucleosome plasma levels in SLE patient. Correlation with serum anti-nucleosome antibody titers and absence of clear association with disease activity. Arthritis Rheum, 1997; 40: 2217-25.
20. GIOUD M, AIT KACI M, MONIER JC: Histone antibodies in systemic lupus erythematosus. Arthritis Rheum, 1982; 25: 407-13.
21. HARDIN JA, THOMAS JO: Antibodies to histones in systemic lupus erythematosus: localization of prominent autoantigens on histones H1 and H2B. Proc Natl Acad Sci USA, 1983; 80: 7410-4.
22. GOHILL J, CARY PD, COUPPEZ M, FRITZLER MJ: Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone. J Immunol, 1985; 135: 3116-21.
23. PORTANOVA JP, CHERONIS JC, BLODGETT JK, KOTZIN BL: Histone autoantigens in murine lupus. Definition of a major epitope within an accessible region of chromatin. J Immunol, 1990; 144: 4633-40.
24. TOTORITIS MC, TAN EM, MCNALLY SR, RUBIN RL: Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus. N Engl J Med, 1988; 318: 1431-6.
25. RUBIN RL, BELL SA, BURLINGAME RW: Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex. J Clin Invest, 1992; 90: 165-73.
26. BURLINGAME RW, RUBIN RL: Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J Immunol Methods, 1990; 134: 187-99.
27. BURLINGAME RW, RUBIN RL, BALDERAS RS, THEOFILOPOULOS AN: Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J Clin Invest, 1993; 91: 1687-96.
28. AMOURA Z, CHABRE H, KOUTOUZOV S, LOTTON C, CABRESPINES A, BACH JF, et al.: Nucleosome-restricted antibodies are detected before anti-dsDNA and/or antihistone antibodies in serum of MRL-Mp lpr/lpr and +/+ mice, and are present in kidney eluates of lupus mice with proteinuria. Arthritis Rheum, 1994; 37: 1684-8.
29. BURLINGAME RW, BOEY ML, RUBIN RL: The central role of chromatin in autoimmune responses to histones and dsDNA in systemic lupus erythematosus. J Clin Invest, 1994; 94: 184-92.
30. CHABRE H, AMOURA Z, PIETTE JC, GODEAU P, BACH JF, KOUTOUZOV S: Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. Arthritis Rheum, 1995; 38: 1485-91.
31. LOSMAN JA, FASY TM, NOVICK KE, MASSA M, MONESTIER M: Monoclonal autoantibodies to subnucleosomes from a MRL/Mp +/+ mouse: oligoclonality of the antibody response and recognition of a determinant composed of histoties H2A, H2B and DNA. J Immunol, 1992; 148: 1561-9.
32. FRANEK F, DOLNIKOVA J: Nucleosomes occuring in protein-free hybridoma cell-culture: evidence for programmed cell death. FEBS Lett, 1991; 284: 285-7.
33. JOVELIN F, MOSTOSLAVSKI G, AMOURA Z, CHABRE H, GILBERT D, EILAT D, et al.: Early anti-nucleosome autoantibodies from a single MRL +/+ mouse: fine specificity, V-gene structure and pathogenicity. Eur J Immunol, 1998; 28: 3411-22.
34. LOSMAN JA, EASY TM, NOVICK KE, MASSA M, MONESTIER M: Nucleosome-specific antibody from an autoimmune MRL/Mp-lpr/lpr mouse. Arthritis Rheum, 1993; 36: 552-60.
35. MONESTIER M, NOVICK KE: Specificities and genetic characteristics of nucleosome-reactive antibodies from autoimmune mice. Mol Immunol, 1996; 33: 89-99.
36. BRARD F, JOVELIN F, PETIT S, TRON F, GILBERT D: Structural properties and mutation patterns of anti-nucleosome monoclonal antibodies are similar to those of anti-DNA antibodies. Eur J Immunol, 1996; 26: 1587-94.
37. STEMMER C, RICHALET-SECORDEL P, VAN BRUGGEN M, KRAMERS K, BERDEBN JH, MULLER S: Reactivity of several monoclonal anti-nucleosome autoantibodies for double-stranded and a short segment of histone H3. J Biol Chem, 1996; 271: 21257-61.
38. MOHAN C, ADAMS S, STANIK V, DATTA SK: Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med, 1993; 177: 1367-81.
39. VOLL RE, ROTH EA, GIRONTAITE I, FEHR H, HERRMANN M, LORENZ HM, et al.: Histone-specific ThO and Th1 clones derived from systemic lupus erythematosus induce double-stranded DNA antibody production. Arthritis Rheum, 1997; 40: 2162-71.
40. KALIYAPERUMAL A, MOHAN C, WU W, DATTA SK: Nucleosomal peptide epitopes for nephritis-inducing T helper T cells of murine lupus. J Exp Med, 1996; 183: 2459-69.
41. KALIYAPERUMAL A, MICHAELS MA, DATTA SK: Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus. J Immunol, 2002; 168: 2530-7.
42. DECKER P, LE MOAL A, BRIAND JP, MULLER S: Identification of a minimal T cell epitope recognized by antinucleosome Th cells in the C-terminal region of the histone H4. J Immunol, 2000; 15: 654-62.
43. KALIYAPERUMAL A, MICHAELS MA, DATTA SK: Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells. J Immunol, 1999; 162: 5775-83.
44. HAHN BH, SINGH RR, WONG WK, TSAO BP, BULPITT K, EBLING FM: Treatment with consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus. Arthritis Rheum, 2001; 44: 432-41.
45. WU HY, WARD FJ, STAINES NA: Histone peptide-induced nasal tolerance: suppression of murine lupus. J Immunol, 2002; 169: 1126-34.
46. FOSTER MH, CIZMAN B, MADAIO MP: Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins. Lab Invest, 1993; 69: 494-507.
47. SUZUKI N, HARADA T, MIZUSHIMA Y, SAKANE T: Possible pathogenic role of cationic anti-ADN autoantibodies in the development in the of nephritis in patients with patients with systemic lupus erythematosus. J Immunol, 1993; 151: 1128-36.
48. MADAIO MP, CARLSON J, CATALDO J, UCCI A, MIGLIORINI P, PANKEWYCZ O: Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits. J Immunol, 1987; 138: 2883-9.
49. SABBAGO J, LINE SRP, POTOCNJAK P, MADAIO PM: A murine nephritogenic monoclonal anti-DNA autoantibody binds directly to mouse laminin, the major non-collagenous protein component of the glomerular basement membrane. Eur J Immunol, 1989; 19: 137-41.
50. FAABER P, RIJKE GPM, VAN DE PUTTE LBA, CAPEL PJA, BERDEN JHM: Crossreactivity of human and murine anti-DNA antibodies with heparan sulfate: the major glycosaminoglycan in glomerar basement membrane. J Clin Invest, 1986; 77: 1824-30.
51. TERMAAT RM, BRINKMAN K, VAN GOMPEL F, VAN DE HEUVEL LPWJ, VEERKAMP JH, SMEENK RJT, et al.: Crossreactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes. J Autoimmun, 1990; 3: 531-45.
52. AMOURA Z, PIETTE JC, BACH JF, KOUTOUZOV S: The key role of nucleosomes in lupus. Arthritis Rheum, 1999; 42: 833-43.
53. CORITSIDIS GN, BEERS PC, RUMORE P: Glomerular uptake of nucleosomes: evidence for receptor-mediated mesangial cell binding. Kidney Int, 1995; 47: 1258-65.
54. KOUTOUZOV S, CABRESPINES A, AMOURA Z, CHABRE H, LOTTON C, BACH JF: Binding of nucleosomes to a cell surface receptor: redistribution and endocytosis in the presence of lupus antibodies. Eur J Immunol, 1996; 26: 472-86.
55. CHAN TM, FRAMPTON G, STAINES NA, HOBBY P, PERRY GJ, CAMERON JS: Different mechanisms by which anti-DNA MoAbs bind to human endothelial cells and glomerular mesangial cells. Clin Exp Immunol, 1992; 88: 68-74.
56. KRAMERS K, HYLKEMA MN, VAN BRUGGEN MCJ, VAN DE LAGEMAAT R, DIJKMAN HB, ASSMANN KJ, et al.: Antinucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vitro. J Clin Invest, 1994; 94: 568-77.
57. VAN BRUGGEN MC, KRAMERS K, HYLKEMA MN, VAN DEN BORN J, BAKKER MA, ASSMANN KJ, et al.: decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis. Am J Pathol, 1995; 146: 753-64.
58. TERMAAT RM, ASSMANN KJ, DIJKMAN HB, VAN GOMPEL, SMEENK RJ, BERDEN JH: Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int, 1992; 42: 1363-71.
59. TAX WJ, KRAMERS C, VAN BRUGGEN MC, BERDEN JH: Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. Kidney Int, 1995; 48: 666-73.
60. BERDEN JH: Lupus nephritis. Kidney Int, 1997; 52: 538-58.
61. EMLEN W, HOLERS VM, AREND WP, KOTZIN B: Regulation of nuclear antigen expression on the cell surface of human monocytes. J Immunol, 1992; 148: 3042-8.
62. JACOB L, VIARD JP, ALLENET B, ANIN MF, SLAMA FBH, VANDEKERCKOVE J, et al.: A monoclonal anti-double-stranded DNA autoantibody binds to a 94-kDa cell-surface protein on various cell types via nucleosomes or a DNA-histone complex. Proc Natl Acad Sci USA, 1989; 86: 4669-73.
63. HEFENEIDER SH, CORNELL KA, BROWN LE, BAKKE AC, MC COY SL, BENNETT RM: Nucleosomes and DNA bind to specific cell-surface molecules on murine cells and induce cytokine production. Clin Immunol Immunopathol, 1992; 63: 245-51.
64. BELL DA, MORRISON B: The spontaneous apoptotic death of normal human lymphocytes in vitro: the release of, and immunoproliferative response to, nucleosomes in vitro. Clin Immunol Immunopathol, 1991; 60: 13-6.
65. BELL DA, MORRISON B, VANDENBYGAART P: Immunogenic DNA-related factors: nucleosomes spontaneously released from normal murine lymphoid cells stimulate proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J Clin Invest, 1990; 85: 1487-96.
66. LELANN AD, FOURNIÉ GJ, BOISSIER L, TOUTAIN PL, BENOIST H: In vitro inhibition of natural-killer-mediated lysis by chromatin fragments. Cancer Immunol Immunother, 1994; 39: 185-92.
67. LADERACH AD, BACH JF, KOUTOUZOV S: Nucleosomes inhibit phagocytosis of apoptotic thymocytes by peritoneal macrophages from MRL +/+ lupus prone-mice. J Leukoc Biol, 1998; 68: 774-80.
68. CORITSIDIS GN, LOMBARDO F, RUMORE P, KUO SF, Izzo R, MiR R, et al.: Nucleosome effects on mesangial cell matrix and proliferation: a possible role in early lupus nephritis. Exp Nephrol, 2002; 10: 216-26.
69. Yu D, RUMORE PM, LIU Q, STEINMAN CR: Soluble oligonucleosomal complexes in synovial fluid from inflamed joints. Arthritis Rheum, 1997; 40: 648-54.
70. LICHT R, VAN BRUGGEN MC, OPPERS-WALGREEN B, RIJKE TP, BERDEN JH: Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolysaccharide administration. Arthritis Rheum, 2001; 44: 1320-30.
71. AMOURA Z, KOUTOUZOV S, CHABRE H, CACOUB P, AMOURA I, MUSSET L, et al.: Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Arthritis Rheum, 2000; 43: 76-84.
72. BRUNS A, BLASS S, HAUSDORF G, BURMESTER GR, HIEPE F: Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus. Arthritis Rheum, 2000; 43: 2307-15.
73. MIN DJ, KIM SJ, PARK SH, SEO YI, KANG HJ, KIM WU, et al.: Anti-nucleosome antibody: significance in lupus patients lacking anti-double-stranded DNA antibody. Clin Exp Rheumatol, 2002; 20: 13-8.